@article{a477458fc0ff4cbbaf11a3b9390f6b0f,
title = "Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial",
author = "Martijn Visser and Sankha Amarakoon and TOAR Missotten and Reinier Timman and \{van Busschbach\}, Jan",
year = "2020",
doi = "10.1007/s11136-020-02580-9",
language = "English",
volume = "29",
pages = "3305--3313",
journal = "Quality of Life Research",
issn = "0962-9343",
publisher = "Springer Netherlands",
number = "12",
}